Detalles de la búsqueda
1.
Patients with neuropsychiatric involvement systemic lupus erythematosus experience poorer health-related quality of life and more fatigue than systemic lupus erythematosus patients with no neuropsychiatric involvement, irrespective of neuropsychiatric activity.
Rheumatology (Oxford)
; 2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38579198
2.
Factors associated with non-adherence to medications in systemic lupus erythematosus: Results from a Swedish survey.
Lupus
; 33(6): 615-628, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38545763
3.
Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus.
J Autoimmun
; 136: 103025, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36996699
4.
Sensitivity analysis of EQ-5D-3L index scores in terms of discriminative and known-groups validity in SLE: introducing Adequate Health State.
Rheumatology (Oxford)
; 62(12): 3916-3923, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36946293
5.
Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus.
Rheumatology (Oxford)
; 61(12): 4752-4762, 2022 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35302581
6.
Impact of overweight and obesity on patient-reported health-related quality of life in systemic lupus erythematosus.
Rheumatology (Oxford)
; 60(3): 1260-1272, 2021 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32918459
7.
Contribution of abnormal BMI to adverse health-related quality of life outcomes after a 52-week therapy in patients with SLE.
Rheumatology (Oxford)
; 60(9): 4205-4217, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33404659
8.
EQ-5D-3L full health state discriminates between drug and placebo in clinical trials of systemic lupus erythematosus.
Rheumatology (Oxford)
; 60(10): 4703-4716, 2021 10 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33502473
9.
Corrigendum to 'Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus' [J. Autoimmun. 136 (April 2023) 103025].
J Autoimmun
; : 103052, 2023 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37142531
10.
Factors Associated with Survival and Discontinuation of Anti-Malarial Agents in Systemic Lupus Erythematosus: Results from a Tertiary Swedish Referral Centre.
J Clin Med
; 13(5)2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38592294
11.
OMERACT 2023 Systemic Lupus Erythematosus Special Interest Group: Winnowing and Binning Preliminary Candidate Domains for the Core Outcome Set.
Semin Arthritis Rheum
; 65: 152380, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38281467
12.
Impact of Belimumab on Patient-Reported Outcomes in Systemic Lupus Erythematosus: Insights from Clinical Trials and Real-World Evidence.
Patient Relat Outcome Meas
; 14: 1-13, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36699199
13.
Obesity is associated with pain and impaired mobility despite therapy in systemic lupus erythematosus.
Front Med (Lausanne)
; 10: 1247354, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37692782
14.
How Can We Enhance Adherence to Medications in Patients with Systemic Lupus Erythematosus? Results from a Qualitative Study.
J Clin Med
; 11(7)2022 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35407466
15.
EQ-5D full health state after therapy heralds reduced hazard to accrue subsequent organ damage in systemic lupus erythematosus.
Front Med (Lausanne)
; 9: 1092325, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36606059
16.
Adverse Health-Related Quality of Life Outcome Despite Adequate Clinical Response to Treatment in Systemic Lupus Erythematosus.
Front Med (Lausanne)
; 8: 651249, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33937290
17.
Use of Antimalarial Agents is Associated with Favourable Physical Functioning in Patients with Systemic Lupus Erythematosus.
J Clin Med
; 9(6)2020 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32532059
Resultados
1 -
17
de 17
1
Próxima >
>>